Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Influenza
RSV (Respiratory syncytial virus)
Children
Pregnant women
Americas
Western Pacific
Clear all
Type of publications
NITAG documentation
(4)
Systematic reviews (SYSVAC)
(1)
Topics
Available to download in languages
Regions
Americas
(3)
Western Pacific
(2)
Africa
(1)
Europe
(6)
Countries
Australia
(1)
Chile
(2)
United States of America
(1)
Diseases
Influenza
(2)
RSV (Respiratory syncytial virus)
(3)
COVID-19
(15)
Hepatitis B
(3)
Human papillomavirus (HPV)
(1)
Japanese encephalitis
(1)
Meningococcal disease
(2)
Pertussis
(1)
Pneumococcal disease
(9)
Rotavirus
(8)
Varicella
(1)
Vaccine topics
Coverage
(1)
Economic aspects
(1)
Efficacy/effectiveness
(1)
Logistics
(1)
Target population
Children
(3)
Pregnant women
(2)
Adolescents
(2)
All age groups
(6)
Healthcare workers
(3)
Newborn
(1)
Older adults
(3)
Parents/caregivers
(1)
Publication date
2024
(1)
2023
(2)
2019
(1)
2013
(1)
5 results found
2024
∙
ATAGI
ATAGI statement on Nirsevimab for the prevention of severe disease due to respiratory syncytial virus (RSV) in infants
2023
∙
CAVEI
CAVEI RECOMMENDATION ON VACCINATION INCORPORATION AGAINST RESPIRATORY SYNCYCIAL VIRUS IN OLDER ADULTS AND PREGNANT WOMEN IN THE NATIONAL IMMUNIZATION PROGRAM
2023
∙
ACIP
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices
2019
∙
CAVEI
CAVEI's position on including children 6-10 years of age as target group in influenza campaigns starting in 2020
2013
∙
Samaan, G. McPherson, M. Partridge, J.
A Review of the Evidence to Support Influenza Vaccine Introduction in Countries and Areas of WHO's Western Pacific Region
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register